Who
Dongfang Liu
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Nuvation Bio.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $2.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jul 2022
- Last trade
- 17 Apr 2026
- Last filed
- 21 Apr 2026
Companies traded
Activity over time
1 Apr 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $97K50,000 at $1.94 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $251K50,000 at $5.02 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $97K50,000 at $1.94 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $251K50,000 at $5.02 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —150,000 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $440K150,000 at $2.93 | filing |
| 1 Dec 2025filed 3 Dec 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $1.2M150,000 at $7.82 | filing |
| 26 Nov 2025filed 26 Nov 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 26 Nov 2025filed 26 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $36K10,000 at $3.61 | filing |
| 26 Nov 2025filed 26 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $80K10,000 at $8.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $36K10,000 at $3.61 | filing |
| 25 Nov 2025filed 26 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $75K10,000 at $7.50 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $37K20,000 at $1.87 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $140K20,000 at $7.00 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Dongfang Liu; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.